05 Aug 2019 – Destiny Pharma welcomes the US government’s healthcare reform ...
Destiny Pharma welcomes the US government’s healthcare reform for novel antibacterial drug payments which include an alternative pathway for New Technology Add-On Payments (NTAPs) which increases the value of these […]